Literature DB >> 19625394

Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors.

Kathrina Quinn1, Melinda A Brindley, Melodie L Weller, Nikola Kaludov, Andrew Kondratowicz, Catherine L Hunt, Patrick L Sinn, Paul B McCray, Colleen S Stein, Beverly L Davidson, Ramon Flick, Robert Mandell, William Staplin, Wendy Maury, John A Chiorini.   

Abstract

To explore mechanisms of entry for Ebola virus (EBOV) glycoprotein (GP) pseudotyped virions, we used comparative gene analysis to identify genes whose expression correlated with viral transduction. Candidate genes were identified by using EBOV GP pseudotyped virions to transduce human tumor cell lines that had previously been characterized by cDNA microarray. Transduction profiles for each of these cell lines were generated, and a significant positive correlation was observed between RhoC expression and permissivity for EBOV vector transduction. This correlation was not specific for EBOV vector alone as RhoC also correlated highly with transduction of vesicular stomatitis virus GP (VSVG) pseudotyped vector. Levels of RhoC protein in EBOV and VSV permissive and nonpermissive cells were consistent with the cDNA gene array findings. Additionally, vector transduction was elevated in cells that expressed high levels of endogenous RhoC but not RhoA. RhoB and RhoC overexpression significantly increased EBOV GP and VSVG pseudotyped vector transduction but had minimal effect on human immunodeficiency virus (HIV) GP pseudotyped HIV or adeno-associated virus 2 vector entry, indicating that not all virus uptake was enhanced by expression of these molecules. RhoB and RhoC overexpression also significantly enhanced VSV infection. Similarly, overexpression of RhoC led to a significant increase in fusion of EBOV virus-like particles. Finally, ectopic expression of RhoC resulted in increased nonspecific endocytosis of fluorescent dextran and in formation of increased actin stress fibers compared to RhoA-transfected cells, suggesting that RhoC is enhancing macropinocytosis. In total, our studies implicate RhoB and RhoC in enhanced productive entry of some pseudovirions and suggest the involvement of actin-mediated macropinocytosis as a mechanism of uptake of EBOV GP and VSVG pseudotyped viral particles.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625394      PMCID: PMC2747995          DOI: 10.1128/JVI.00422-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

Review 1.  Rho GTPases and their effector proteins.

Authors:  A L Bishop; A Hall
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

Review 2.  Farnesyltransferase inhibitors define a role for RhoB in controlling neoplastic pathophysiology.

Authors:  G C Prendergast
Journal:  Histol Histopathol       Date:  2001-01       Impact factor: 2.303

3.  Entry of the two infectious forms of vaccinia virus at the plasma membane is signaling-dependent for the IMV but not the EEV.

Authors:  J K Locker; A Kuehn; S Schleich; G Rutter; H Hohenberg; R Wepf; G Griffiths
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

Review 4.  Dissecting virus entry via endocytosis.

Authors:  Sara B Sieczkarski; Gary R Whittaker
Journal:  J Gen Virol       Date:  2002-07       Impact factor: 3.891

5.  Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity.

Authors:  Rachel L Kaletsky; Graham Simmons; Paul Bates
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

6.  Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses.

Authors:  S Y Chan; R F Speck; M C Ma; M A Goldsmith
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 7.  Emergence and re-emergence of vesicular stomatitis in the United States.

Authors:  Luis L Rodríguez
Journal:  Virus Res       Date:  2002-05-10       Impact factor: 3.303

8.  Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses.

Authors:  S Y Chan; C J Empig; F J Welte; R F Speck; A Schmaljohn; J F Kreisberg; M A Goldsmith
Journal:  Cell       Date:  2001-07-13       Impact factor: 41.582

9.  COMPARE: a web accessible tool for investigating mechanisms of cell growth inhibition.

Authors:  Daniel W Zaharevitz; Susan L Holbeck; Christopher Bowerman; Penny A Svetlik
Journal:  J Mol Graph Model       Date:  2002-01       Impact factor: 2.518

10.  Association of the caveola vesicular system with cellular entry by filoviruses.

Authors:  Cyril J Empig; Mark A Goldsmith
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

View more
  52 in total

1.  The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus.

Authors:  Catherine L Hunt; Andrey A Kolokoltsov; Robert A Davey; Wendy Maury
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

2.  Filamentous influenza virus enters cells via macropinocytosis.

Authors:  Jeremy S Rossman; George P Leser; Robert A Lamb
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

3.  The cytoplasmic domain of Marburg virus GP modulates early steps of viral infection.

Authors:  Eva Mittler; Larissa Kolesnikova; Bettina Hartlieb; Robert Davey; Stephan Becker
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

4.  Macropinocytosis-like HIV-1 internalization in macrophages is CCR5 dependent and leads to efficient but delayed degradation in endosomal compartments.

Authors:  Lise-Andrée Gobeil; Robert Lodge; Michel J Tremblay
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

5.  Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy.

Authors:  Jessica Sallach; Giovanni Di Pasquale; Fernando Larcher; Nadine Niehoff; Matthias Rübsam; Anke Huber; Jay Chiorini; David Almarza; Sabine A Eming; Hikmet Ulus; Stephen Nishimura; Ulrich T Hacker; Michael Hallek; Carien M Niessen; Hildegard Büning
Journal:  Mol Ther       Date:  2014-01-28       Impact factor: 11.454

6.  Small rho GTPases and cholesterol biosynthetic pathway intermediates in African swine fever virus infection.

Authors:  Jose I Quetglas; Bruno Hernáez; Inmaculada Galindo; Raquel Muñoz-Moreno; Miguel A Cuesta-Geijo; Covadonga Alonso
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

7.  Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pig.

Authors:  Thomas R Lane; Christopher Massey; Jason E Comer; Alexander N Freiberg; Huanying Zhou; Julie Dyall; Michael R Holbrook; Manu Anantpadma; Robert A Davey; Peter B Madrid; Sean Ekins
Journal:  Antiviral Res       Date:  2020-07-16       Impact factor: 5.970

8.  Macropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35.

Authors:  Stefan Kälin; Beat Amstutz; Michele Gastaldelli; Nina Wolfrum; Karin Boucke; Menzo Havenga; Fabienne DiGennaro; Nicole Liska; Silvio Hemmi; Urs F Greber
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

Review 9.  Exploitation of Cytoskeletal Networks during Early Viral Infection.

Authors:  Derek Walsh; Mojgan H Naghavi
Journal:  Trends Microbiol       Date:  2018-07-20       Impact factor: 17.079

10.  Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner.

Authors:  Asuka Nanbo; Masaki Imai; Shinji Watanabe; Takeshi Noda; Kei Takahashi; Gabriele Neumann; Peter Halfmann; Yoshihiro Kawaoka
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.